Global Genome Sequencing Market Competitive Strategies And Forecasts To 2033 | F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA

The genome sequencing global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

Genome Sequencing Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

Market Size –
The genome sequencing market size has grown rapidly in recent years. It will grow from $8.33 billion in 2023 to $9.89 billion in 2024 at a compound annual growth rate (CAGR) of 18.7%. The growth in the historic period can be attributed to increasing research funding, growing awareness of personalized medicine, rise in genomic data, expansion of clinical applications, and increasing demand for biomarker discovery.
The genome sequencing market size is expected to see rapid growth in the next few years. It will grow to $19.87 billion in 2028 at a compound annual growth rate (CAGR) of 19.1%. The growth in the forecast period can be attributed to growth in genomic research, an increase in the prevalence of genetic disorders, increasing cancer occurrence, integration with other omics, and rising public awareness and acceptance. Major trends in the forecast period include advancements in next-generation sequencing (NGS) technologies, integration with artificial intelligence (AI) and machine learning (ML), expansion of direct-to-consumer (DTC) genetic testing, development of portable sequencing devices, and the rise of personalized medicine.

Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/genome-sequencing-global-market-report

Scope Of Genome Sequencing Market
The Business Research Company’s reports encompass a wide range of information, including:

1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.

2. Drivers: Examination of the key factors propelling market growth.

3. Trends: Identification of emerging trends and patterns shaping the market landscape.

4. Key Segments: Breakdown of the market into its primary segments and their respective performance.

5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.

6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

Genome Sequencing Market Overview

Market Drivers –
The increasing occurrence of cancer is expected to propel the growth of the genome sequencing market going forward. Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells, which can lead to death if not controlled. The occurrence of cancer is rising due to several factors, including the aging population, lifestyle factors, environmental exposures, and genetic predispositions. Genome sequencing helps identify genetic mutations and predispositions to cancer, enabling early detection and personalized treatment plans. It reveals inherited cancer risks and assists in tracking the development of cancerous cells. For instance, in February 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, new cancer cases are projected to reach over 35 million by 2050, representing a 77% increase compared to 20 million cases in 2022. Therefore, the increasing occurrence of cancer is driving the growth of the genome sequencing market.

Market Trends –
Major companies operating in the genome sequencing market are focused on developing advanced solutions, such as next-generation sequencing (NGS)-based assays, to enhance the accuracy of genetic analysis and enable personalized medicine approaches. Next-generation sequencing (NGS)-based assays refer to advanced genomic technologies that will allow rapid and high-throughput sequencing of DNA or RNA to analyze genetic material. NGS allows for the simultaneous sequencing of millions of fragments of DNA or RNA, generating large volumes of data quickly and at a lower cost. For instance, in April 2023, Centogene N.V., a Germany-based provider of genetic diagnostics for rare diseases, launched CentoGenome, an enhanced Next Generation Sequencing (NGS)-based assay. It offers lifelong diagnostic support with proactive diagnosis confirmation and reclassification programs at no extra cost, ensuring continuous patient care and precise disease management. Utilizing a PCR-free approach, CentoGenome reduces bias and enhances sequencing quality, providing better coverage of challenging genomic regions and improving insights into coding, regulatory, and intronic areas. The platform features an automated bioinformatics pipeline and medical expert analysis, utilizing CENTOGENE’s extensive bio databank of data from about 700,000 patients in over 120 countries. This comprehensive dataset boosts the detection of disease-causing variants, including those associated with spinal muscular atrophy and Parkinson’s disease.

The genome sequencing market covered in this report is segmented –
1) By Product: Consumables, Systems And Software, Services
2) By Technology: Polymerase Chain Reaction (PCR), Sequencing, Microarray, Nucleic Acid Extraction, Purification, Other Technologies
3) By Applications: Diagnostics, Drug Discovery, Precision Medicine, Environmental Genomics, Research, Other Applications
4) By End-User: Hospitals And Clinics, Biotechnology And Pharmaceutical Companies, Contract Research Organizations (CROs), Government, Research Centers, Academic And Government Institutes, Other End-Users

Get an inside scoop of the genome sequencing market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=19484&type=smp

Regional Insights –
North America was the largest region in the genome sequencing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genome sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Key Companies –
Major companies operating in the genome sequencing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, Becton, Dickinson and Company, Eurofins Genomics, Agilent Technologies Inc., PerkinElmer, Illumina Inc., bioMérieux, Bio-Rad Laboratories Inc., QIAGEN N.V., 10x Genomics Inc., BGI Group, Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., GENEWIZ Inc., LI-COR Inc., CENTOGENE N.V., Bioneer Corporation, Strand Life Sciences Pvt Ltd., Nebula Genomics< /b>

Table of Contents
1. Executive Summary
2. Genome Sequencing Market Report Structure
3. Genome Sequencing Market Trends And Strategies
4. Genome Sequencing Market – Macro Economic Scenario
5. Genome Sequencing Market Size And Growth
…..
27. Genome Sequencing Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model”